Effect of Pitavastatin and EPA on coronary artery calcification detected by computed tomography.

Trial Profile

Effect of Pitavastatin and EPA on coronary artery calcification detected by computed tomography.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Sep 2017

At a glance

  • Drugs Pitavastatin (Primary) ; Eicosapentaenoic acid
  • Indications Atherosclerosis; Coronary artery disease; Dyslipidaemias
  • Focus Therapeutic Use
  • Acronyms PEACH
  • Most Recent Events

    • 01 Sep 2017 Primary endpoint (CAC volume) has not been met as per the results published in the Circulation Journal
    • 01 Sep 2017 Primary endpoint (The effect of Pitavastatin on coronary calcification score.) has not been met as per the results published in the Circulation Journal
    • 01 Sep 2017 Results published in the Circulation Journal
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top